Menu
  • Facilities
  • Careers
  • Newsroom
  • Resources
  • Blogs
  • Facilities
  • Careers
  • Newsroom
  • Resources
  • Blogs
  • Office Hour : 08:00am - 6:00pm
Cohance light logo
  • About Us
    • About Cohance
    • Purpose, Values & Promise
    • Leadership
    • Quality, Regulatory & Compliance
    • Science & Technology
  • Small Molecule API
    • API Development
    • API Manufacturing
  • ADCs
    • Integrated CRDMO
    • ADC Payloads
    • Payloads & Linkers
  • Nucleic Acid Chemistry
    • Nucleosides & Phosphoramidites Development
    • Nucleosides & Phosphoramidites Manufacturing
    • Products
  • Generic APIs
    • Product List
  • Specialty Chemicals
    • Agrochemicals
  • Investors
    • Financial Info
    • Shareholder Info
    • Corporate Governance
    • Corporate Info
    • Disclosure under Reg 46 of SEBI LODR
  • Sustainability
    • Our ESG Commitment
    • Sustainability in Action
    • Our ESG Aspirations
    • ESG Profile
    • Policies
    • Reports
    • Corporate Social Responsibility
  • Global Presence
  • Events
  • Facilities
  • Careers
  • Newsroom
  • Resources
  • Blogs
  • Contact Us
  • About Us
    • About Cohance
    • Purpose, Values & Promise
    • Leadership
    • Quality, Regulatory & Compliance
    • Science & Technology
  • Small Molecule API
    • API Development
    • API Manufacturing
  • ADCs
    • Integrated CRDMO
    • ADC Payloads
    • Payloads & Linkers
  • Nucleic Acid Chemistry
    • Nucleosides & Phosphoramidites Development
    • Nucleosides & Phosphoramidites Manufacturing
    • Products
  • Generic APIs
    • Product List
  • Specialty Chemicals
    • Agrochemicals
  • Investors
    • Financial Info
    • Shareholder Info
    • Corporate Governance
    • Corporate Info
    • Disclosure under Reg 46 of SEBI LODR
  • Sustainability
    • Our ESG Commitment
    • Sustainability in Action
    • Our ESG Aspirations
    • ESG Profile
    • Policies
    • Reports
    • Corporate Social Responsibility
  • Global Presence
  • Events
  • Facilities
  • Careers
  • Newsroom
  • Resources
  • Blogs
  • Contact Us
Close
Contact Us

In The News

Cohance Lifesciences :In The News
  • In The News
  • Press Releases
  • Events

29th September 2026

Bridging Speed and First-Time-Right Scale-Up


VIEW DETAILS →

28th September 2026

Panel discussion on..
ESG & Strategic Partnerships in Pharma Supply Chain - Chemistry Today


VIEW DETAILS →

24th September 2026

Panel discussion on..
ESG & Strategic Partnerships in Pharma Supply Chain - Cohance Lifesciences


VIEW DETAILS →

12th September 2026

Cohance Lifesciences:
A Global CDMO Platform with
Multi-Modality Expertise


VIEW DETAILS →

9th April 2026

Project Management and Process Improvements for CDMOs
(Page 16 - 17)

VIEW DETAILS →

2nd Feburary 2026

What emerging technologies or scientific breakthroughs do you believe will most reshape biopharma in the next 10 years?

VIEW DETAILS →

5th January 2026

Looking back over the last 30 years, what advance has had the greatest impact on the industry — and why?

VIEW DETAILS →

5th January 2026

How are capital constraints impacting M&A and strategic partnerships in the CDMO and pharma sectors?

VIEW DETAILS →

3rd November 2025

What economic or market trends are having the biggest impact on CDMO capacity and pipelines in 2025, and what will 2026 bring?
VIEW DETAILS →

3rd November 2025

What do you consider to be the most important new tools or technology platforms currently being developed?

VIEW DETAILS →

3rd November 2025

What do you see as the biggest threat to the CDMO industry in 2026 or beyond?


VIEW DETAILS →

November 2025

How to negotiate CDMO Contracts for Flexibility and Cost Control


VIEW DETAILS →

November 2025

How to negotiate CDMO Contracts for Flexibility and Cost Control

VIEW DETAILS →

About Us

  • About Cohance
  • Purpose, Values & Promise
  • Leadership
  • Sustainability
  • Quality, Regulatory
    & Compliance
  • Science & Technology

Small Molecule API

  • API Development
  • API Manufacturing

ADCs

  • Integrated CRDMO
  • ADC Payloads

Nucleic Acid Chemistry

  • Nucleosides &
    Phosphoramidites
    Development
  • Nucleosides &
    Phosphoramidites
    Manufacturing
  • Products

Generic APIs

  • Product List

Specialty Chemicals

  • Agro Chemicals

Investors

  • Financial Info
  • Shareholder Info
  • Corporate Governance
  • Corporate Info
  • Disclosure under
    Reg 46 of SEBI LODR

Resources

  • Brochures
  • Videos

Blogs

Newsroom

  • In The News
  • Press Releases
  • Events

Cohance Lifesciences Limited

(Formerly, Suven Pharmaceuticals Limited)
CIN: L24299MH2018PLC422236

Follow Us
Linkedin
Youtube
  • Terms Of Use
  • Privacy Policy
  • © 2026 Cohance Lifesciences Ltd. All rights reserved.
Cohance logo
  • About Us
    • About Cohance
    • Purpose, Values & Promise
    • Leadership
    • Quality, Regulatory & Compliance
    • Science & Technology
  • Small Molecule API
    • API Development
    • API Manufacturing
  • ADCs
    • Integrated CRDMO
    • ADC Payloads
    • Payloads & Linkers
  • Nucleic Acid Chemistry
    • Nucleosides & Phosphoramidites Development
    • Nucleosides & Phosphoramidites Manufacturing
    • Products
  • Generic APIs
    • Product List
  • Specialty Chemicals
    • Agrochemicals
  • Investors
    • Financial Info
    • Shareholder Info
    • Corporate Governance
    • Corporate Info
    • Disclosure under Reg 46 of SEBI LODR
  • Sustainability
    • Our ESG Commitment
    • Sustainability in Action
    • Our ESG Aspirations
    • ESG Profile
    • Policies
    • Reports
    • Corporate Social Responsibility
  • Global Presence
  • Events
  • Facilities
  • Careers
  • Newsroom
  • Resources
  • Blogs
  • Contact Us
Top